While GPC5 expression is downregulated in breast cancer, glioma, hepatocellular carcinoma, lung cancer, pancreatic cancer, prostate cancer, it results in being upregulated in rhabdomyosarcoma [35,134,135,136,137,138]. Here, GPC5 is linked to rhabdomyosarcoma.